Hollencrest Capital Management Novartis Ag Transaction History
Hollencrest Capital Management
- $2.2 Billion
- Q1 2025
A detailed history of Hollencrest Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Hollencrest Capital Management holds 232 shares of NVS stock, worth $27,106. This represents 0.0% of its overall portfolio holdings.
Number of Shares
232
Previous 232
-0.0%
Holding current value
$27,106
Previous $22,000
13.64%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,551Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.38 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.21 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.01 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$824 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$790 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...